NAOV - ナノビブロニクス （NanoVibronix Inc.）NAOVのニュース
NanoVibronix files for US patent linked to UroShield device 2023/03/21 13:33:44 Seeking Alpha
NanoVibronix (NAOV) filed a provisional patent application with the U.S
NanoVibronix says study shows benefit of UroShield in spinal cord injury patients 2023/03/14 13:44:48 Seeking Alpha
NanoVibronix (NAOV) said an independent study showed that the UroShield device demonstrated a decrease in the number of blockages and infections and increase in catheter satisfaction…
Can NanoVibronix Inc. (NASDAQ: NAOV) Still Be Considered A Loss When It’s Up 20.04% YTD? 2023/02/11 20:00:00 Marketing Sentinel
During the last session, NanoVibronix Inc. (NASDAQ:NAOV)’s traded shares were 3.73 million, with the beta value of the company hitting 0.86. At the end of the trading day, the stock’s price was $6.05, reflecting an intraday gain of 38.13% or $1.67. The 52-week high for the NAOV share is $27.20, that puts it down -349.59 … Can NanoVibronix Inc. (NASDAQ: NAOV) Still Be Considered A Loss When It’s Up 20.04% YTD? Read More »
NanoVibronix falls 11% on 1-for-20 reverse stock split 2023/02/08 17:55:55 Seeking Alpha
NanoVibronix (NAOV) said it plans to effect a reverse stock split at a ratio of 1 post-split share for every 20 pre-split shares.The reverse stock split will become effective at 4:05 p.m
NanoVibronix Announces Reverse Stock Split | MarketScreener 2023/02/08 17:02:02 MarketScreener
Common Stock Will Begin Trading on Split-Adjusted Basis on February 9, 2023 … | February 8, 2023
NanoVibronix files for FDA clearance of ultrasound pain therapy device PainShield MD Plus 2022/05/04 13:06:18 Seeking Alpha
NanoVibronix (NAOV) said it submitted a 510(k) application to the U.S. Food and Drug Administration ((FDA)) seeking clearance of PainShield MD PLUS, an ultrasound pain therapy…
NanoVibronix Announces FDA 510(k) Submission for PainShield MD PLUS 2022/05/04 12:30:00 Wallstreet:Online
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its PainShield MD PLUS, its dual-actuator ultrasound pain therapy device. Brian Murphy, CEO of NanoVibronix, stated,
Infatuating stocks: NanoVibronix, Inc. (NASDAQ:NAOV -3.71%), salesforce.com, inc. (NYSE:CRM -3.22%) 2022/04/15 01:20:05 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Infatuating stocks: NanoVibronix, Inc. (NASDAQ:NAOV -3.71%), salesforce.com, inc. (NYSE:CRM -3.22%) appeared first on Stocks Equity .
Hot Stock to Observe: NanoVibronix, Inc. (NASDAQ:NAOV), Ra Medical Systems, Inc. (AMEX:RMED) 2022/04/09 02:22:25 Stock Equity
NanoVibronix, Inc. (NAOV) with the stream of -12.39% also noticed, India Ra Medical Systems, Inc. (RMED) encountered a rapid change of 3.33% in the last hour of Friday’s trading session. … The post Hot Stock to Observe: NanoVibronix, Inc. (NASDAQ:NAOV), Ra Medical Systems, Inc. (AMEX:RMED) appeared first on Stocks Equity .
NanoVibronix Alert: Why NAOV Stock Is Skyrocketing 133% Today 2020/12/02 15:15:25 InvestorPlace
A NanoVibronix (NAOV) alert for investors is in order Wednesday as the medical device company's stock is skyrocketing higher.
NanoVibronix Expands Offerings with Introduction of PainShield Plus® 2020/10/16 12:30:00 Business Wire
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of multiple areas of pain in tandem. Brian Murphy, CEO of NanoVibronix, stated, “The introduction of PainShield Plus is a natural extension of our hig
NanoVibronix News: Why NAOV Stock Is Skyrocketing 104% Today 2020/09/22 20:02:38 InvestorPlace
NanoVibronix (NAOV) news for Tuesday includes approval from the U.S. Food and Drug Administration sending NAOV stock soaring.
The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study 2020/09/04 11:28:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3) Akouos Inc (NASDAQ: AKUS ) FibroGen Inc (NASDAQ: FGEN )(reacted to an adverse clinical readout for a rival drug to treat chronic kidney disease related anemia) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Sutro Biopharma Inc (NASDAQ: STRO ) ( reacted to announcement concerning presentation of positive data for ovarian cancer drug) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 3) Akebia Therapeutics Inc (NASDAQ: AKBA ) (announced negative safety results for a late-stage study of drug to treat chronic kidney disease-induced anemia) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Genfit SA (NASDAQ: GNFT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Homology Medicines Inc (NASDAQ: FIXX ) Immatics NV (NASDAQ: IMTX ) Interpace Biosciences Inc (NASDAQ: IDXG ) Jaguar Health Inc (NASDAQ: JAGX ) Legend Biotech Corp (NASDAQ: LEGN ) Monopar Therapeutics Inc (NASDAQ: MNPR ) NanoVibronix Inc (NASDAQ: NAOV ) Odonate Therapeutics Inc (NASDAQ: ODT ) RA Medical Systems Inc (NYSE: RMED ) Recro Pharma Inc (NASDAQ: REPH ) Rockwell Medical Inc (NASDAQ: RMTI ) Soliton Inc (NASDAQ: SOLY ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Teligent Inc (NASDAQ: TLGT ) Related Link: Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates Stocks In Focus Lilly Gets FDA Nod For 2 Higher Doses of Its Best-selling Diabetes Drug Eli Lilly And Co (NYSE: LLY ) said the FDA approved two additional doses of its Type 2 diabetes drug Trulicity.
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax 2020/09/03 11:55:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …